Sodexo (SW) H2 2024 earnings summary

Executive summary

• Fiscal 2024 was transformative, marked by the spin-off of Pluxee, sale of Sofinsod, and simplification of the group to focus on Food and FM services, with proceeds returned to shareholders via special dividends.

• Achieved strong financial performance with organic revenue growth of 7.9% and revenues of €23.8 billion, supported by strategic advances in branded food offers, digital transformation, and operational efficiency.

• Significant investments in technology, AI, and supply chain optimization, alongside strengthened sustainability impact with reduced emissions and food waste.

• Record year for new signings, exceeding €1.6 billion, despite a dip in client retention due to large contract losses.

• The group is now a focused food and targeted FM services player in 45 countries, with a simplified structure and enhanced operational execution.

Financial highlights

• Organic revenue growth reached 7.9%, with food services up 9.3% and now comprising 66% of total revenues.

• Underlying operating margin improved by 40 bps to 4.7%; underlying net income from continuing activities rose 17.6% to €775 million.

• Operating profit increased 24.1% to over €1 billion; underlying operating profit was €1.1 billion, up 13.7%.

• Free cash flow was €661 million, up nearly €290 million year-over-year, with a 90% cash conversion rate.

• Net debt reduced by €380 million to €2.6 billion; net debt/EBITDA ratio improved to 1.7x, within the 1-2x target range.

• Total shareholder return reached 29%, boosted by the special dividend.

Outlook and guidance

• Fiscal 2025 organic revenue growth projected at 5.5%-6.5% (6%-7% excluding event base effects), with pricing expected to contribute ~3%.

• Underlying operating profit margin anticipated to improve by 30-40 bps at constant currency.

• Like-for-like volume growth expected from increased workplace attendance, upselling, and cross-selling; net new contribution targeted at ~2%, with stronger growth in H2.

• Scope change to impact Q1 FY25 revenue growth by about -1% due to Homecare sale; tax rate for FY25 projected at ~27%.